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Abstract
The prevalence of chronic kidney disease on dialysis or CKD5D is increasing with a significant impact on disease 
burden in many countries. Patients are usually listed in the national renal registries, which report demographic 
data, incidence, prevalence, and outcome. The survival rate is an important outcome measure to characterize the 
impact of treatment in the CKD5 patient population in the national and international renal registries. Indonesian 
Society of Nephrology (InaSN) has the Indonesian Renal Registry program to collect data that was endorsed to 
monitor dialysis treatment quality in Indonesia. IRR releases an annual report, but there is no survival analysis 
yet.   This study aimed to discover the five-year survival rate of CKD5D patients in West Java between 2007–2018 
and its factor based on the IRR database. A retrospective cohort study was performed by gaining all patients' data 
from the IRR database, then data on all of the patients from West Java province who completed a 5-year follow-up 
on December 31, 2018.  Kaplan-Meier analysis and Cox proportional hazard's model were used to analyze the risk 
factors. There were 3,199 data included in this study. In total, the 1, 2, 3, 4, and 5 year survival rates are 82%, 70%, 
62%, 58%, and 55 %, respectively.  Patients whose age is above 55 years and with unknown underlying kidney 
disease have a worse survival rate with a hazard ratio of 1.28 and 1.50, respectively. Further exploration of IRR 
data will provide better information on dialysis treatment in Indonesia.
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Ketahanan Hidup Pasien Penyakit Ginjal Kronis dengan Hemodialisis di 
Jawa Barat Indonesia tahun 2007–2018
Abstrak
Prevalensi penyakit ginjal kronis pada dialisis atau PGK5D meningkat dan memberi beban penanganan penyakit 
di banyak negara. Pasien biasanya terdaftar dalam register ginjal nasional yang melaporkan data demografis, 
insiden, prevalensi dan luaran klisis. Tingkat ketahanan hidup merupakan parameter penting dalam registrasi 
ginjal untuk menggambarkan kualitas terapi pada populasi pasien PGK stadium 5. Perhimpunan Nefrologi 
Indonesia (Pernefri) memiliki program Registri Ginjal Indonesia yang disebut Indonesian Renal Registry (IRR) 
untuk mengumpulkan data pasien PGK5D untuk  memantau kualitas pengobatan dialisis di Indonesia. Indonesian 
Renal Registry merilis laporan tahunan tetapi belum dilengkapi dengan  analisis ketahanan hidup. Tujuan penelitian 
ini adalah mengetahui angka ketahanan hidup lima tahun pasien PGK5D di Jawa Barat antara tahun 2007-2018 
dan faktor risikonya berdasarkan basis data dari IRR. Studi kohort retrospektif dengan mengambil semua data 
pasien dari basis data IRR kemudian ditentukan data pasien Jawa Barat yang lengkap dan di follow up selama 
5 tahun pada 31 Desember 2018. Analisis Kaplan-Meier dan model proporsional hazard Cox digunakan untuk 
menganalisis faktor risiko. Subjek berjumlah 3199 data yang dimasukkan dalam penelitian ini. Kesimpulannya, 
angka harapan hidup satu, 2, 3, 4, dan 5 tahun berturut-turut adalah 82%, 70%, 62%, 58%, dan 55%. Usia lebih 
dari 55 tahun dan penyakit ginjal yang mendasari memiliki kelangsungan hidup yang lebih buruk dengan hazard 
ratio 1,28 dan 1,50. Eksplorasi lebih lanjut dari data IRR akan memberikan informasi yang lebih baik tentang 
perawatan dialisis di Indonesia.
Kata kunci: Hemodialisis, ketahanan, registrasi
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Introduction
The prevalence of chronic kidney disease in 
dialysis or CKD5D patients is increasing with 
a significant impact of disease burden in many 
countries (USRDS 2017).1 Although various 
treatment methods have been developed and 
successfully prolonged patients’ lives with end-
stage kidney disease, the survival rates of CKD5D 
patients in general remain poor. USRDS reported 
that the adjusted survival rate for patients 
on hemodialysis (HD) is 57% at three years, 
which is much lower than that of patients on 
peritoneal dialysis (PD) and patients receiving 
deceased donor transplantation (58% and 85%, 
respectively).1 
The survival rates of CKD5D patients in 
different countries vary. For example, people 
with hemodialysis in Europe have an average 
of 86.9% of 1 (one) year survival rate2 and the 
United Kingdom Renal Registry, in particular, 
has reported a survival rate of 96.6 % in 90 days 
and 90.4 % in one year.3 In contrast with those 
numbers, in developing countries like Nigeria, 
the survival rate in 90 days and one year is only 
66,8 % and 25 %, respectively.4  
Survival rate is one of the most critical 
outcome measures and is influenced by individual 
risk factors, such as the type of underlying 
kidney disease, age, and comorbidities, as well 
as the health system factors such as dialysis 
care facility and financing system.  Because the 
patient survival rate estimation needs valid and 
reliable data input, since 1977 the International 
Federation of Renal Registries (IFRR) has 
endorsed the dialysis registry implementation 
for every country to monitor dialysis treatment 
improvement.5
The Indonesian Renal Registry (IRR) was 
established by the Indonesian Society of 
Nephrology in 2007 and continues to collect 
patient dialysis data based on voluntary 
submission from the care units across the 
country. The participation rate is improving 
over the years and in 2018, it 85% of dialysis 
units had submitted their data from all areas of 
Indonesia, with West Java province as the area 
that contribute most with 95% of the overall 
data submitted come from facilities in West 
Java province area.5 Although the IRR annual 
report has been released since a long time ago, 
data on survival rate of patient on dialysis was 
unfortunately reported at that time. The first 
attempt to estimate the survival rate based 
on the IRR data was made in 2012 through a 
collaborative study which resulted in a survival 
rate of 77.6 % in the first year and 44.3 % in 5 
years. Unfortunately, the finding was limited 
because the IRR data only covered approximately 
50% of all dialysis units in Indonesia at that time. 
This study aimed to determine the survival 
rate and some risk factors of hemodialysis 
patients in West Java based on the updated 
Indonesian Renal Registry data. This will 
potentially provide more reliable information on 
the survival rate of Indonesian CKD5D patients 
on dialysis care.
Methods
This study was a retrospective cohort study 
that reviewed patients with CKD5 who received 
maintenance hemodialysis as recorded in the 
IRR database. The IRR database consists of 
patient data starting the first dialysis treatment. 
The patient data include name, gender, date of 
birth, address, name of the dialysis unit, city, 
and province of the dialysis unit, date of first 
dialysis treatment, etiology or underlying kidney 
disease, comorbid disease, dialysis frequency, 
date of the last treatment, and cause of finished 
the treatment.  The inclusion criteria were all 
patients who were registered between January 
1, 2007 and December 31, 2018 with complete 
follow-up information for 5 years at the end of 
2018. The IRR admin provided patient data, 
information regarding date of the first dialysis, 
age, sex, etiology or underlying kidney disease, 
and date of the last dialysis as extracted from the 
database. Patients with incomplete data were 
excluded from the analysis 
The composite endpoint of the analysis was 
a loss to follow up that means the patient who 
did not come in 90 consecutive days to the 
previous dialysis unit or another dialysis unit in 
Indonesia and cannot be reached by phone or 
mail and patient who died.  We choose 3 kinds of 
risk factors - gender, age, and etiology of kidney 
disease category. Patients’ follow-ups were 
censored at the time of death or loss to follow 
up before the end of 2018.  Three variables on 
survival risk factors comprised sex, age, and 
etiology of kidney disease were evaluated. 
Originally the etiology in IRR was classified 
into ten categories and to reduce the degree of 
freedom, the classification was simplified into 
five categories, namely: Primary kidney disease: 
Primary glomerulopathy and Polycystic kidney 
disease, Diabetic Kidney Disease, Hypertensive 
Nephrosclerosis, Other Secondary Kidney 
Disease: Lupus Nephritis, Pyelonephritis chronic, 
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Sample : West Java data 
66438




Cleaning data : 






Subject who finished 5 year follow up on
1st December 2018
Cleaning data : 
>1 missing data
Figure 1 Patient Recruitment Flow Diagram
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Urate Nephropathy, Obstructive Nephropathy, 
others and Unknown 
To maintain the confidentiality of this study, 
all analyses were using de-identified data. The 
Ethical Committee Faculty of Medicine University 
Padjadjaran approved the study protocol (Ethical 
Clearance Letter No: 33/UN6.KEP/EC/2020).
Descriptive data of subject’s characteristics 
and survival rate were described by medians or 
means for continuous variables and by number 
and percentage for categorical variables. Kaplan-
Meier analysis and Cox proportional hazard’s 
model were used to analyze the risk factors. 
The hazard ratio was calculated for comparison 
of risk factors by category. The statistical 
significance was defined at the level of p-values 
<0.05. All statistical calculation was performed 
by R statistical software version 4.0.2.
Result
A total of 66,438 patients were in the database 
of West Java Province. Of these,  only 23,821 
met the inclusion criteria, and 3,204 patients 
had complete data for the entire 5 years follow-
up at the end of 2018.  There were five patients 
excluded from the survival analysis due to 
missing data, resulting in 3,199 patients included 
in the analysis of survival. 
Fifty-six percent of the respondents were 
male with the median age of 52 years old.  Most 
of the patients (55.1%) were at the age of 40–59 
years.  The age groups were further divided into 
two groups with a cut-off point of 55 years old 
for risk factor analysis. Twenty-three-point-eight 
percent of patients had hypertension and 20.5% 
of patients had diabetes mellitus as the etiology 
of chronic kidney disease.  
Out of 3,199 patients, 1,431 (47.4%) finished 
the treatment as an event.  The median length of 
patients with hemodialysis was 376 days for loss 
to follow up and 787 days for patients who died.
There was no significant difference in survival 
when the two genders were compared. There 
was a significant difference between below and 
above 55 years old.
A significant difference was seen in terms 
of patient survival. Patients with hypertensive 
nephrosclerosis had better survival, followed by 
patients with diabetic kidney disease, primary 
kidney disease, other secondary kidney diseases, 
and unknown 
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Loss to follow up 376 (1–3797)
Death 787 (1–4811)










Age (year), median (min, max)  52 (7,95)






Primary glomerulopathy 413 (12,9)
Diabetic kidney disease 656 (20,5)
Hypertensive nephrosclerosis 761 (23,8)
Other secondary kidney diseases 1141 (35.6)
Unknown 232 (7,2)
Figure 2 Kaplan Meier- Survival of all patient's
Figure 3 Kaplan–Meier–Patient Survival as  
   Stratified by Gender  Figure 4  Kaplan–Meier–Patient Survival as  
    Stratified by Age Group
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Discussion
In this cohort study, data from the IRR database 
were used. The dialysis unit has to upload data 
online of every single patient who undergoes 
dialysis since their first treatment and should 
report again when they end the treatment for 
any reason. The    IRR collects some demographic 
variables, clinical condition variables, dialysis 
prescription including adequacy assessment, 
laboratory results, and cause of death.   Data 
were updated every six months and the IRR 
publishes its report annually in online and print 
versions.  IRR always welcome providing data of 
scientific research purpose.  
The uptake of data collection was not very 
good in the beginning, which was 13 years ago, 
and is getting better recently. InaSN has 12 
region coordinators and the IRR admin evaluates 
the data uptake based on these regions.  Every 
region has a person in charge (PIC) who 
evaluates the problems of data sending in their 
regions. West Java province has been succeeded 
in sending their patient data since the beginning 
with complete data uptake of always more than 
90 % annually.  West Java is the province with 
the biggest population size in the country which 
is still growing until now. The population of this 
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Table 3 Survival Rate 
Survival Rate (%)
95% CI













































































































Table 4 Cox Proportional Hazard Model
Hazard Ratio 95 % Confidence Interval p–value
Gender
Female Reference - -
Male 0.89 0,798–0.989 0.2
Age
<55 years Reference - -
>55 years 1.28 0.780–1.148 0.001
Underlying kidney disease
Primary kidney disease reference - -
Diabetic kidney disease 0.75 0.619– 0.913 0.01
Hypertensive nephrosclerosis 0.46 0.375–0.566 0.001
Other secondary kidney disease 1.24 1.048– 1.469 0.05
Unknown 1.50 1.203–1.888 0.001
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Figure 5 Kaplan–Meier of Patients Stratified by  
   Underlying Kidney Disease
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province was 42 million in 2009 and increases 
to 49.02 million in 2019, comprising of 18.9 
% of the total population of Indonesia (269.6 
million).5 The IRR has launched many programs 
to increase data uptake from other regions. 
Fortunately, in the last 3 years, the national data 
uptake has achieved more than 80%. There are 
about 200,000 hemodialysis patients recorded 
in the IRR database at the end of 2018.5
Not many countries in the world perform 
survival analysis based on a national renal 
registry report.  Some countries have a perfect 
registry, such as the United Kingdom Renal 
Registry, Australia and New Zealand Data, 
Malaysian Renal Registry, and ERA EDTA Renal 
Registry. These registries have established 
excellent quality in data analysis and reporting. 
The IRR follows their paths to improve the 
registry. The quality of the database in the 
registry should be maintained to give a perfect 
result.  The survival rate should be included in 
the registry report to give a complete description 
of dialysis treatment in Indonesia.
In this cohort study, data were obtained 
very easily. The IRR provided the data set that 
was already cleaned in the excel format. A final 
check was performed and only five records have 
five missing data out of 3,204 patients. The 
number of subjects was significant enough when 
compared to other five-year survival analysis 
studies based on the registry.6-11  This study 
analyzed the survival as stratified by age, gender, 
and underlying kidney disease, which is similar 
to others .6-17.
One year survival rate was 82.4 %, similar 
with the rate in Taiwan in 2009 (81.1)8, Kelantan 
Malaysia 2018 (89.5)14 and Iran 2010 (89.2)15, 
but lower than the Singapore Renal Registry 
2017 (90.5)6, Malaysian Renal Registry  2016 
(94)7, South African Registry 2018 (90.1)9, 
Finnish Registry 2012 (89.9)10, and ANZ Data 
2016 (94)11.  The survival in this study is better 
than the USRDS 2018 78.31, Iran 2018 (65)16, 
and Nigeria 2019 (24.8%)18.  Interestingly, the 
present study showed a 5-year survival rate of 
55.3 %, which is better than Taiwan (44.2)8 and 
USRDS (42.07)1, but similar to Malaysian Renal 
Registry (53)7 and lower than Singapore Renal 
Registry (61.1) 8 and Australia and New Zealand 
Data (69%)11.   
In this registry-based study, gender does not 
relate to survival and it is similar to SRR and 
MRR.6.7  Age is established as a risk factor for 
survival, and this study chose 55 years old as cut-
off based on the age of retirement in Indonesia. 
Age more than 55 years old shows significantly 
worse survival with Hazard Ratio (HR) 1.28. 
Other studies also show a similar result that 
older patient has worse survival as in USRDS, 
SRR, MRR, UKRR, ERA EDTARegistry, Japan 
Registry, and ANZData.  However, those studies 
use different age grouping and HR increased as 
the age grouping older.1.2,4,6,7,11
As age, underlying kidney disease was known 
as a risk factor for survival. Diabetic Kidney 
Disease was known as a leading cause of CKD 
in many countries.1,2,7 Most survival analyses 
compare diabetic and non-diabetic as underlying 
kidney disease and exhibit diabetic patients 
to have worse survival than non-diabetic 
patients.6.10,17,18 Report of IRR shows that diabetes 
is not the leading cause but hypertension is.6  
Some registries or countries also report that 
diabetes is not the leading cause of CKD.12,18 The 
incidence of hypertensive kidney disease varies 
around the world. For instance, it accounts for 
as many as 25% and 17% of patients starting 
dialysis for end-stage kidney disease in Italy 
and France, respectively. Japan and China have 
lower numbers. Hypertensive kidney disease 
increases globally since the year of 2000 by 8.7 
%. Hypertension is not always reported as the 
specific cause of kidney disease, therefore, the 
number may be underestimated.20 According 
to IRR data, the underlying kidney disease 
groups were categorized into 5 categories in this 
study, i.e. Primary Kidney Disease (or Primary 
glomerulopathy), Diabetic Kidney Disease, 
Hypertensive Nephrosclerosis/ Hypertensive 
Kidney Disease, Other Secondary Kidney Disease 
(Lupus Nephritis, Urate Nephropathy, Chronic 
Pyelonephritis, obstructive nephropathy, and 
others ) and Unknown.  In this Cohort study, 
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primary kidney disease is a reference for Cox 
proportional analysis.  Patients in the unknown 
group have a significantly worse outcome with 
an HR of 1.5, followed by other secondary 
kidney diseases with an HR of 1.24, Diabetic 
kidney disease patients have an HR of 0.75 while 
patients with hypertensive kidney disease have 
an HR of 0.46. This finding was in contrast with 
our expectation since it was presumed that 
diabetic kidney disease patients have a worse 
prognosis than other diseases. This result needs 
to be validated following the wide range of 
diseases in other secondary kidney diseases or 
other categories.  A possible explanation for this 
result is that the IRR has no information about 
the severity of each disease and the comorbid 
conditions was not included as a risk category 
in the analysis in this study. A previous study 
based on the IRR data showed that patients 
with hypertension as a comorbid have similar 
survival probability with those who have no 
hypertension. MRR presented the same result, 
stating that patients with unknown underlying 
kidney disease has worse survival than others 
with an HR of 1.39.7  
The present study has several significant 
limitations, including no multivariate analysis 
of risk factors for survival such as comorbid 
condition, dialysis adequacy, nutritional status, 
and health facility factors. Indonesia, as a big 
developing country, had no national health 
insurance system during the period recorded 
in the IRR. Most patients paid their dialysis 
treatment out of their pocket.  The financing 
system might influence the survival as well as 
dialysis unit shortage 
Despite these limitations, the present study 
provided some useful information. The survival 
rate in Indonesia as a developing country is 
not worse than in some developed countries. 
This result gives valuable information to all 
stakeholders in making better policies for 
delivering dialysis service in Indonesia.
In conclusion, 1-,2-,3-,4-, and 5-year survival 
rates are 82,70,62,58, and 55% respectively. Age 
and underlying kidney disease become the risk 
factors.  Further exploration of IRR data will give 
better information about dialysis treatment in 
Indonesia.
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